APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Oral Finasteride Tablet

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Oral Finasteride Tablet Market Outlook and Growth Opportunities 2026

Report ID 174019810430 December 2025213 pages

Choose your research edition.

Industry ResearchOral Finasteride Tablet Industry Research Report 2026150 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Finasteride Tablet Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal Oral Finasteride Tablet Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Finasteride Tablet Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Finasteride Tablet Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

The global Oral Finasteride Tablet market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Oral Finasteride Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Oral Finasteride Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oral Finasteride Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Oral Finasteride Tablet market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Oral Finasteride Tablet market include Zhejiang Xianju Pharmaceutical Co., Ltd, Tianfang Pharmaceutical Co., Ltd, Shanghai Xinya Pharmaceutical Minhang Co., Ltd, Shanghai Hyundai Pharmaceutical Co., Ltd, Sandoz, Renhetang Pharmaceutical Company Limited, Nanjing Shenghe Pharmaceutical Co., Ltd, Nanjing Sea Whale Pharmaceutical Co., Ltd and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Oral Finasteride Tablet market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oral Finasteride Tablet and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oral Finasteride Tablet sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Oral Finasteride Tablet market size, projected growth trends, production technologies, key applications, and end-use industries.

Oral Finasteride Tablet Segment by Company

Zhejiang Xianju Pharmaceutical Co., Ltd

Tianfang Pharmaceutical Co., Ltd

Shanghai Xinya Pharmaceutical Minhang Co., Ltd

Shanghai Hyundai Pharmaceutical Co., Ltd

Sandoz

Renhetang Pharmaceutical Company Limited

Nanjing Shenghe Pharmaceutical Co., Ltd

Nanjing Sea Whale Pharmaceutical Co., Ltd

Merck

Runenberg Pharmaceuticals Ltd

CR SECCO Pharmaceutical Co., Ltd

Hunan Zhengqing Pharmaceutical Group Co., Ltd

Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd

Hunan Baicao Pharmaceutical Co., Ltd

Hangzhou Kangenbei Pharmaceutical Co., Ltd

Guangdong Yishu Pharmaceutical Co., Ltd

RelonChem

Dr. Reddy

Cipla

Actavis

Accord Pharmaceuticals

Oral Finasteride Tablet Segment by Type

1mg

5mg

Oral Finasteride Tablet Segment by Application

Urology

Dermatology

Oral Finasteride Tablet Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Oral Finasteride Tablet status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Oral Finasteride Tablet market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Oral Finasteride Tablet significant trends, drivers, influence factors in global and regions.

6. To analyze Oral Finasteride Tablet competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Finasteride Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Finasteride Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Finasteride Tablet.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Oral Finasteride Tablet market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Oral Finasteride Tablet industry.

Chapter 3: Detailed analysis of Oral Finasteride Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Oral Finasteride Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Oral Finasteride Tablet in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Oral Finasteride Tablet Industry Trends Table 2. Oral Finasteride Tablet Industry Drivers Table 3. Oral Finasteride Tablet Industry Opportunities and Challenges Table 4. Oral Finasteride Tablet Industry Restraints Table 5. Global Oral Finasteride Tablet Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Oral Finasteride Tablet Revenue Share by Company (2021-2026) Table 7. Global Oral Finasteride Tablet Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Oral Finasteride Tablet Sales Volume Share by Company (2021-2026) Table 9. Global Oral Finasteride Tablet Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Oral Finasteride Tablet Company Ranking, (2024-2026) & (USD Million) Table 11. Global Oral Finasteride Tablet Key Company Manufacturing Base & Headquarters Table 12. Global Oral Finasteride Tablet Company, Product Type & Application Table 13. Global Oral Finasteride Tablet Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Oral Finasteride Tablet by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 1mg Table 18. Significant Companies of 5mg Table 19. Global Oral Finasteride Tablet Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Oral Finasteride Tablet Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Oral Finasteride Tablet Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Oral Finasteride Tablet Sales Volume Share by Type (2021-2026) Table 23. Global Oral Finasteride Tablet Sales Volume Share by Type (2027-2032) Table 24. Global Oral Finasteride Tablet Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Oral Finasteride Tablet Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Oral Finasteride Tablet Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Oral Finasteride Tablet Sales Value Share by Type (2021-2026) Table 28. Global Oral Finasteride Tablet Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Urology Table 30. Significant Companies of Dermatology Table 31. Global Oral Finasteride Tablet Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Oral Finasteride Tablet Sales Volume by Application (2021-2026) & (K Units) Table 33. Global Oral Finasteride Tablet Sales Volume by Application (2027-2032) & (K Units) Table 34. Global Oral Finasteride Tablet Sales Volume Share by Application (2021-2026) Table 35. Global Oral Finasteride Tablet Sales Volume Share by Application (2027-2032) Table 36. Global Oral Finasteride Tablet Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Oral Finasteride Tablet Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Oral Finasteride Tablet Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Oral Finasteride Tablet Sales Value Share by Application (2021-2026) Table 40. Global Oral Finasteride Tablet Sales Value Share by Application (2027-2032) Table 41. Global Oral Finasteride Tablet Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Oral Finasteride Tablet Sales by Region (2021-2026) & (K Units) Table 43. Global Oral Finasteride Tablet Sales Market Share by Region (2021-2026) Table 44. Global Oral Finasteride Tablet Sales by Region (2027-2032) & (K Units) Table 45. Global Oral Finasteride Tablet Sales Market Share by Region (2027-2032) Table 46. Global Oral Finasteride Tablet Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Oral Finasteride Tablet Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Oral Finasteride Tablet Sales Value Share by Region (2021-2026) Table 49. Global Oral Finasteride Tablet Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Oral Finasteride Tablet Sales Value Share by Region (2027-2032) Table 51. Global Oral Finasteride Tablet Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Oral Finasteride Tablet Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Oral Finasteride Tablet Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Global Oral Finasteride Tablet Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Oral Finasteride Tablet Sales by Country (2021-2026) & (K Units) Table 56. Global Oral Finasteride Tablet Sales Market Share by Country (2021-2026) Table 57. Global Oral Finasteride Tablet Sales by Country (2027-2032) & (K Units) Table 58. Global Oral Finasteride Tablet Sales Market Share by Country (2027-2032) Table 59. Global Oral Finasteride Tablet Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Oral Finasteride Tablet Sales Value Market Share by Country (2021-2026) Table 61. Global Oral Finasteride Tablet Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Oral Finasteride Tablet Sales Value Market Share by Country (2027-2032) Table 63. Zhejiang Xianju Pharmaceutical Co., Ltd Company Information Table 64. Zhejiang Xianju Pharmaceutical Co., Ltd Business Overview Table 65. Zhejiang Xianju Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Zhejiang Xianju Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio Table 67. Zhejiang Xianju Pharmaceutical Co., Ltd Recent Development Table 68. Tianfang Pharmaceutical Co., Ltd Company Information Table 69. Tianfang Pharmaceutical Co., Ltd Business Overview Table 70. Tianfang Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Tianfang Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio Table 72. Tianfang Pharmaceutical Co., Ltd Recent Development Table 73. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Company Information Table 74. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Business Overview Table 75. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Oral Finasteride Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Oral Finasteride Tablet Product Portfolio Table 77. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Recent Development Table 78. Shanghai Hyundai Pharmaceutical Co., Ltd Company Information Table 79. Shanghai Hyundai Pharmaceutical Co., Ltd Business Overview Table 80. Shanghai Hyundai Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Shanghai Hyundai Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio Table 82. Shanghai Hyundai Pharmaceutical Co., Ltd Recent Development Table 83. Sandoz Company Information Table 84. Sandoz Business Overview Table 85. Sandoz Oral Finasteride Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Sandoz Oral Finasteride Tablet Product Portfolio Table 87. Sandoz Recent Development Table 88. Renhetang Pharmaceutical Company Limited Company Information Table 89. Renhetang Pharmaceutical Company Limited Business Overview Table 90. Renhetang Pharmaceutical Company Limited Oral Finasteride Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Renhetang Pharmaceutical Company Limited Oral Finasteride Tablet Product Portfolio Table 92. Renhetang Pharmaceutical Company Limited Recent Development Table 93. Nanjing Shenghe Pharmaceutical Co., Ltd Company Information Table 94. Nanjing Shenghe Pharmaceutical Co., Ltd Business Overview Table 95. Nanjing Shenghe Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Nanjing Shenghe Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio Table 97. Nanjing Shenghe Pharmaceutical Co., Ltd Recent Development Table 98. Nanjing Sea Whale Pharmaceutical Co., Ltd Company Information Table 99. Nanjing Sea Whale Pharmaceutical Co., Ltd Business Overview Table 100. Nanjing Sea Whale Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Nanjing Sea Whale Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio Table 102. Nanjing Sea Whale Pharmaceutical Co., Ltd Recent Development Table 103. Merck Company Information Table 104. Merck Business Overview Table 105. Merck Oral Finasteride Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Merck Oral Finasteride Tablet Product Portfolio Table 107. Merck Recent Development Table 108. Runenberg Pharmaceuticals Ltd Company Information Table 109. Runenberg Pharmaceuticals Ltd Business Overview Table 110. Runenberg Pharmaceuticals Ltd Oral Finasteride Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Runenberg Pharmaceuticals Ltd Oral Finasteride Tablet Product Portfolio Table 112. Runenberg Pharmaceuticals Ltd Recent Development Table 113. CR SECCO Pharmaceutical Co., Ltd Company Information Table 114. CR SECCO Pharmaceutical Co., Ltd Business Overview Table 115. CR SECCO Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. CR SECCO Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio Table 117. CR SECCO Pharmaceutical Co., Ltd Recent Development Table 118. Hunan Zhengqing Pharmaceutical Group Co., Ltd Company Information Table 119. Hunan Zhengqing Pharmaceutical Group Co., Ltd Business Overview Table 120. Hunan Zhengqing Pharmaceutical Group Co., Ltd Oral Finasteride Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Hunan Zhengqing Pharmaceutical Group Co., Ltd Oral Finasteride Tablet Product Portfolio Table 122. Hunan Zhengqing Pharmaceutical Group Co., Ltd Recent Development Table 123. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Company Information Table 124. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Business Overview Table 125. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio Table 127. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Recent Development Table 128. Hunan Baicao Pharmaceutical Co., Ltd Company Information Table 129. Hunan Baicao Pharmaceutical Co., Ltd Business Overview Table 130. Hunan Baicao Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Hunan Baicao Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio Table 132. Hunan Baicao Pharmaceutical Co., Ltd Recent Development Table 133. Hangzhou Kangenbei Pharmaceutical Co., Ltd Company Information Table 134. Hangzhou Kangenbei Pharmaceutical Co., Ltd Business Overview Table 135. Hangzhou Kangenbei Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Hangzhou Kangenbei Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio Table 137. Hangzhou Kangenbei Pharmaceutical Co., Ltd Recent Development Table 138. Guangdong Yishu Pharmaceutical Co., Ltd Company Information Table 139. Guangdong Yishu Pharmaceutical Co., Ltd Business Overview Table 140. Guangdong Yishu Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Guangdong Yishu Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio Table 142. Guangdong Yishu Pharmaceutical Co., Ltd Recent Development Table 143. RelonChem Company Information Table 144. RelonChem Business Overview Table 145. RelonChem Oral Finasteride Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. RelonChem Oral Finasteride Tablet Product Portfolio Table 147. RelonChem Recent Development Table 148. Dr. Reddy Company Information Table 149. Dr. Reddy Business Overview Table 150. Dr. Reddy Oral Finasteride Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 151. Dr. Reddy Oral Finasteride Tablet Product Portfolio Table 152. Dr. Reddy Recent Development Table 153. Cipla Company Information Table 154. Cipla Business Overview Table 155. Cipla Oral Finasteride Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 156. Cipla Oral Finasteride Tablet Product Portfolio Table 157. Cipla Recent Development Table 158. Actavis Company Information Table 159. Actavis Business Overview Table 160. Actavis Oral Finasteride Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 161. Actavis Oral Finasteride Tablet Product Portfolio Table 162. Actavis Recent Development Table 163. Accord Pharmaceuticals Company Information Table 164. Accord Pharmaceuticals Business Overview Table 165. Accord Pharmaceuticals Oral Finasteride Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 166. Accord Pharmaceuticals Oral Finasteride Tablet Product Portfolio Table 167. Accord Pharmaceuticals Recent Development Table 168. Key Raw Materials Table 169. Raw Materials Key Suppliers Table 170. Oral Finasteride Tablet Distributors List Table 171. Oral Finasteride Tablet Customers List Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Oral Finasteride Tablet Product Image Figure 2. Global Oral Finasteride Tablet Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral Finasteride Tablet Sales Value (2021-2032) & (US$ Million) Figure 4. Global Oral Finasteride Tablet Sales (2021-2032) & (K Units) Figure 5. Global Oral Finasteride Tablet Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Oral Finasteride Tablet Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 1mg Image Figure 10. 5mg Image Figure 11. Global Oral Finasteride Tablet Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Oral Finasteride Tablet Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Oral Finasteride Tablet Sales Volume Share by Type (2021-2032) Figure 14. Global Oral Finasteride Tablet Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Oral Finasteride Tablet Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Oral Finasteride Tablet Sales Value Share by Type (2021-2032) Figure 17. Urology Image Figure 18. Dermatology Image Figure 19. Global Oral Finasteride Tablet Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Oral Finasteride Tablet Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Oral Finasteride Tablet Sales Volume Share by Application (2021-2032) Figure 22. Global Oral Finasteride Tablet Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Oral Finasteride Tablet Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Oral Finasteride Tablet Sales Value Share by Application (2021-2032) Figure 25. Global Oral Finasteride Tablet Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 26. Global Oral Finasteride Tablet Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Oral Finasteride Tablet Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Oral Finasteride Tablet Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Oral Finasteride Tablet Sales Value (2021-2032) & (US$ Million) Figure 30. North America Oral Finasteride Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Oral Finasteride Tablet Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Oral Finasteride Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Oral Finasteride Tablet Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Oral Finasteride Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Oral Finasteride Tablet Sales Value (2021-2032) & (US$ Million) Figure 36. South America Oral Finasteride Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Oral Finasteride Tablet Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Oral Finasteride Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Oral Finasteride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Oral Finasteride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Oral Finasteride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Oral Finasteride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Oral Finasteride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Oral Finasteride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Oral Finasteride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Oral Finasteride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Oral Finasteride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Oral Finasteride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Oral Finasteride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Oral Finasteride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Oral Finasteride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Oral Finasteride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Oral Finasteride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Oral Finasteride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Oral Finasteride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Oral Finasteride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Oral Finasteride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Oral Finasteride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Oral Finasteride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Oral Finasteride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Oral Finasteride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Oral Finasteride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Oral Finasteride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Oral Finasteride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Oral Finasteride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Oral Finasteride Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Oral Finasteride Tablet Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Oral Finasteride Tablet Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • 1mg
  • 5mg
Applications
  • Urology
  • Dermatology
Companies covered
  • Zhejiang Xianju Pharmaceutical Co., Ltd
  • Tianfang Pharmaceutical Co., Ltd
  • Shanghai Xinya Pharmaceutical Minhang Co., Ltd
  • Shanghai Hyundai Pharmaceutical Co., Ltd
  • Sandoz
  • Renhetang Pharmaceutical Company Limited
  • Nanjing Shenghe Pharmaceutical Co., Ltd
  • Nanjing Sea Whale Pharmaceutical Co., Ltd
  • Merck
  • Runenberg Pharmaceuticals Ltd
  • CR SECCO Pharmaceutical Co., Ltd
  • Hunan Zhengqing Pharmaceutical Group Co., Ltd
  • Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd
  • Hunan Baicao Pharmaceutical Co., Ltd
  • Hangzhou Kangenbei Pharmaceutical Co., Ltd
  • Guangdong Yishu Pharmaceutical Co., Ltd
  • RelonChem
  • Dr. Reddy
  • Cipla
  • Actavis
  • Accord Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Oral Finasteride Tablet Sales Value (2021-2032)
  4. 1.2.2 Global Oral Finasteride Tablet Sales Volume (2021-2032)
  5. 1.2.3 Global Oral Finasteride Tablet Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Oral Finasteride Tablet Market Dynamics
  1. 2.1 Oral Finasteride Tablet Industry Trends
  2. 2.2 Oral Finasteride Tablet Industry Drivers
  3. 2.3 Oral Finasteride Tablet Industry Opportunities and Challenges
  4. 2.4 Oral Finasteride Tablet Industry Restraints
3 Oral Finasteride Tablet Market by Company
  1. 3.1 Global Oral Finasteride Tablet Company Revenue Ranking in 2025
  2. 3.2 Global Oral Finasteride Tablet Revenue by Company (2021-2026)
  3. 3.3 Global Oral Finasteride Tablet Sales Volume by Company (2021-2026)
  4. 3.4 Global Oral Finasteride Tablet Average Price by Company (2021-2026)
  5. 3.5 Global Oral Finasteride Tablet Company Ranking (2024-2026)
  6. 3.6 Global Oral Finasteride Tablet Company Manufacturing Base and Headquarters
  7. 3.7 Global Oral Finasteride Tablet Company Product Type and Application
  8. 3.8 Global Oral Finasteride Tablet Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Oral Finasteride Tablet Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Oral Finasteride Tablet Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Oral Finasteride Tablet Market by Type
  1. 4.1 Oral Finasteride Tablet Type Introduction
  2. 4.1.1 1mg
  3. 4.1.2 5mg
  4. 4.2 Global Oral Finasteride Tablet Sales Volume by Type
  5. 4.2.1 Global Oral Finasteride Tablet Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Oral Finasteride Tablet Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Oral Finasteride Tablet Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Oral Finasteride Tablet Sales Value by Type
  9. 4.3.1 Global Oral Finasteride Tablet Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Oral Finasteride Tablet Sales Value by Type (2021-2032)
  11. 4.3.3 Global Oral Finasteride Tablet Sales Value Share by Type (2021-2032)
5 Oral Finasteride Tablet Market by Application
  1. 5.1 Oral Finasteride Tablet Application Introduction
  2. 5.1.1 Urology
  3. 5.1.2 Dermatology
  4. 5.2 Global Oral Finasteride Tablet Sales Volume by Application
  5. 5.2.1 Global Oral Finasteride Tablet Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Oral Finasteride Tablet Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Oral Finasteride Tablet Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Oral Finasteride Tablet Sales Value by Application
  9. 5.3.1 Global Oral Finasteride Tablet Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Oral Finasteride Tablet Sales Value by Application (2021-2032)
  11. 5.3.3 Global Oral Finasteride Tablet Sales Value Share by Application (2021-2032)
6 Oral Finasteride Tablet Regional Sales and Value Analysis
  1. 6.1 Global Oral Finasteride Tablet Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Oral Finasteride Tablet Sales by Region (2021-2032)
  3. 6.2.1 Global Oral Finasteride Tablet Sales by Region: 2021-2026
  4. 6.2.2 Global Oral Finasteride Tablet Sales by Region (2027-2032)
  5. 6.3 Global Oral Finasteride Tablet Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Oral Finasteride Tablet Sales Value by Region (2021-2032)
  7. 6.4.1 Global Oral Finasteride Tablet Sales Value by Region: 2021-2026
  8. 6.4.2 Global Oral Finasteride Tablet Sales Value by Region (2027-2032)
  9. 6.5 Global Oral Finasteride Tablet Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Oral Finasteride Tablet Sales Value (2021-2032)
  12. 6.6.2 North America Oral Finasteride Tablet Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Oral Finasteride Tablet Sales Value (2021-2032)
  15. 6.7.2 Europe Oral Finasteride Tablet Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Oral Finasteride Tablet Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Oral Finasteride Tablet Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Oral Finasteride Tablet Sales Value (2021-2032)
  21. 6.9.2 South America Oral Finasteride Tablet Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Oral Finasteride Tablet Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Oral Finasteride Tablet Sales Value Share by Country, 2025 VS 2032
7 Oral Finasteride Tablet Country-level Sales and Value Analysis
  1. 7.1 Global Oral Finasteride Tablet Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Oral Finasteride Tablet Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Oral Finasteride Tablet Sales by Country (2021-2032)
  4. 7.3.1 Global Oral Finasteride Tablet Sales by Country (2021-2026)
  5. 7.3.2 Global Oral Finasteride Tablet Sales by Country (2027-2032)
  6. 7.4 Global Oral Finasteride Tablet Sales Value by Country (2021-2032)
  7. 7.4.1 Global Oral Finasteride Tablet Sales Value by Country (2021-2026)
  8. 7.4.2 Global Oral Finasteride Tablet Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Oral Finasteride Tablet Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Oral Finasteride Tablet Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Oral Finasteride Tablet Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Oral Finasteride Tablet Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Oral Finasteride Tablet Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Oral Finasteride Tablet Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Oral Finasteride Tablet Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Oral Finasteride Tablet Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Oral Finasteride Tablet Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Oral Finasteride Tablet Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Oral Finasteride Tablet Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Oral Finasteride Tablet Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Oral Finasteride Tablet Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Oral Finasteride Tablet Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Oral Finasteride Tablet Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Oral Finasteride Tablet Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Oral Finasteride Tablet Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Oral Finasteride Tablet Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Oral Finasteride Tablet Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Oral Finasteride Tablet Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Oral Finasteride Tablet Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Oral Finasteride Tablet Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Oral Finasteride Tablet Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Oral Finasteride Tablet Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Oral Finasteride Tablet Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Oral Finasteride Tablet Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Oral Finasteride Tablet Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Oral Finasteride Tablet Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Oral Finasteride Tablet Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Oral Finasteride Tablet Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhejiang Xianju Pharmaceutical Co., Ltd
  2. 8.1.1 Zhejiang Xianju Pharmaceutical Co., Ltd Company Information
  3. 8.1.2 Zhejiang Xianju Pharmaceutical Co., Ltd Business Overview
  4. 8.1.3 Zhejiang Xianju Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zhejiang Xianju Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio
  6. 8.1.5 Zhejiang Xianju Pharmaceutical Co., Ltd Recent Developments
  7. 8.2 Tianfang Pharmaceutical Co., Ltd
  8. 8.2.1 Tianfang Pharmaceutical Co., Ltd Company Information
  9. 8.2.2 Tianfang Pharmaceutical Co., Ltd Business Overview
  10. 8.2.3 Tianfang Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Tianfang Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio
  12. 8.2.5 Tianfang Pharmaceutical Co., Ltd Recent Developments
  13. 8.3 Shanghai Xinya Pharmaceutical Minhang Co., Ltd
  14. 8.3.1 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Company Information
  15. 8.3.2 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Business Overview
  16. 8.3.3 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Oral Finasteride Tablet Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Oral Finasteride Tablet Product Portfolio
  18. 8.3.5 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Recent Developments
  19. 8.4 Shanghai Hyundai Pharmaceutical Co., Ltd
  20. 8.4.1 Shanghai Hyundai Pharmaceutical Co., Ltd Company Information
  21. 8.4.2 Shanghai Hyundai Pharmaceutical Co., Ltd Business Overview
  22. 8.4.3 Shanghai Hyundai Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Shanghai Hyundai Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio
  24. 8.4.5 Shanghai Hyundai Pharmaceutical Co., Ltd Recent Developments
  25. 8.5 Sandoz
  26. 8.5.1 Sandoz Company Information
  27. 8.5.2 Sandoz Business Overview
  28. 8.5.3 Sandoz Oral Finasteride Tablet Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sandoz Oral Finasteride Tablet Product Portfolio
  30. 8.5.5 Sandoz Recent Developments
  31. 8.6 Renhetang Pharmaceutical Company Limited
  32. 8.6.1 Renhetang Pharmaceutical Company Limited Company Information
  33. 8.6.2 Renhetang Pharmaceutical Company Limited Business Overview
  34. 8.6.3 Renhetang Pharmaceutical Company Limited Oral Finasteride Tablet Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Renhetang Pharmaceutical Company Limited Oral Finasteride Tablet Product Portfolio
  36. 8.6.5 Renhetang Pharmaceutical Company Limited Recent Developments
  37. 8.7 Nanjing Shenghe Pharmaceutical Co., Ltd
  38. 8.7.1 Nanjing Shenghe Pharmaceutical Co., Ltd Company Information
  39. 8.7.2 Nanjing Shenghe Pharmaceutical Co., Ltd Business Overview
  40. 8.7.3 Nanjing Shenghe Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Nanjing Shenghe Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio
  42. 8.7.5 Nanjing Shenghe Pharmaceutical Co., Ltd Recent Developments
  43. 8.8 Nanjing Sea Whale Pharmaceutical Co., Ltd
  44. 8.8.1 Nanjing Sea Whale Pharmaceutical Co., Ltd Company Information
  45. 8.8.2 Nanjing Sea Whale Pharmaceutical Co., Ltd Business Overview
  46. 8.8.3 Nanjing Sea Whale Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Nanjing Sea Whale Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio
  48. 8.8.5 Nanjing Sea Whale Pharmaceutical Co., Ltd Recent Developments
  49. 8.9 Merck
  50. 8.9.1 Merck Company Information
  51. 8.9.2 Merck Business Overview
  52. 8.9.3 Merck Oral Finasteride Tablet Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Merck Oral Finasteride Tablet Product Portfolio
  54. 8.9.5 Merck Recent Developments
  55. 8.10 Runenberg Pharmaceuticals Ltd
  56. 8.10.1 Runenberg Pharmaceuticals Ltd Company Information
  57. 8.10.2 Runenberg Pharmaceuticals Ltd Business Overview
  58. 8.10.3 Runenberg Pharmaceuticals Ltd Oral Finasteride Tablet Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Runenberg Pharmaceuticals Ltd Oral Finasteride Tablet Product Portfolio
  60. 8.10.5 Runenberg Pharmaceuticals Ltd Recent Developments
  61. 8.11 CR SECCO Pharmaceutical Co., Ltd
  62. 8.11.1 CR SECCO Pharmaceutical Co., Ltd Company Information
  63. 8.11.2 CR SECCO Pharmaceutical Co., Ltd Business Overview
  64. 8.11.3 CR SECCO Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 CR SECCO Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio
  66. 8.11.5 CR SECCO Pharmaceutical Co., Ltd Recent Developments
  67. 8.12 Hunan Zhengqing Pharmaceutical Group Co., Ltd
  68. 8.12.1 Hunan Zhengqing Pharmaceutical Group Co., Ltd Company Information
  69. 8.12.2 Hunan Zhengqing Pharmaceutical Group Co., Ltd Business Overview
  70. 8.12.3 Hunan Zhengqing Pharmaceutical Group Co., Ltd Oral Finasteride Tablet Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Hunan Zhengqing Pharmaceutical Group Co., Ltd Oral Finasteride Tablet Product Portfolio
  72. 8.12.5 Hunan Zhengqing Pharmaceutical Group Co., Ltd Recent Developments
  73. 8.13 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd
  74. 8.13.1 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Company Information
  75. 8.13.2 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Business Overview
  76. 8.13.3 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio
  78. 8.13.5 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Recent Developments
  79. 8.14 Hunan Baicao Pharmaceutical Co., Ltd
  80. 8.14.1 Hunan Baicao Pharmaceutical Co., Ltd Company Information
  81. 8.14.2 Hunan Baicao Pharmaceutical Co., Ltd Business Overview
  82. 8.14.3 Hunan Baicao Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Hunan Baicao Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio
  84. 8.14.5 Hunan Baicao Pharmaceutical Co., Ltd Recent Developments
  85. 8.15 Hangzhou Kangenbei Pharmaceutical Co., Ltd
  86. 8.15.1 Hangzhou Kangenbei Pharmaceutical Co., Ltd Company Information
  87. 8.15.2 Hangzhou Kangenbei Pharmaceutical Co., Ltd Business Overview
  88. 8.15.3 Hangzhou Kangenbei Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Hangzhou Kangenbei Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio
  90. 8.15.5 Hangzhou Kangenbei Pharmaceutical Co., Ltd Recent Developments
  91. 8.16 Guangdong Yishu Pharmaceutical Co., Ltd
  92. 8.16.1 Guangdong Yishu Pharmaceutical Co., Ltd Company Information
  93. 8.16.2 Guangdong Yishu Pharmaceutical Co., Ltd Business Overview
  94. 8.16.3 Guangdong Yishu Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Guangdong Yishu Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio
  96. 8.16.5 Guangdong Yishu Pharmaceutical Co., Ltd Recent Developments
  97. 8.17 RelonChem
  98. 8.17.1 RelonChem Company Information
  99. 8.17.2 RelonChem Business Overview
  100. 8.17.3 RelonChem Oral Finasteride Tablet Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 RelonChem Oral Finasteride Tablet Product Portfolio
  102. 8.17.5 RelonChem Recent Developments
  103. 8.18 Dr. Reddy
  104. 8.18.1 Dr. Reddy Company Information
  105. 8.18.2 Dr. Reddy Business Overview
  106. 8.18.3 Dr. Reddy Oral Finasteride Tablet Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Dr. Reddy Oral Finasteride Tablet Product Portfolio
  108. 8.18.5 Dr. Reddy Recent Developments
  109. 8.19 Cipla
  110. 8.19.1 Cipla Company Information
  111. 8.19.2 Cipla Business Overview
  112. 8.19.3 Cipla Oral Finasteride Tablet Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Cipla Oral Finasteride Tablet Product Portfolio
  114. 8.19.5 Cipla Recent Developments
  115. 8.20 Actavis
  116. 8.20.1 Actavis Company Information
  117. 8.20.2 Actavis Business Overview
  118. 8.20.3 Actavis Oral Finasteride Tablet Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Actavis Oral Finasteride Tablet Product Portfolio
  120. 8.20.5 Actavis Recent Developments
  121. 8.21 Accord Pharmaceuticals
  122. 8.21.1 Accord Pharmaceuticals Company Information
  123. 8.21.2 Accord Pharmaceuticals Business Overview
  124. 8.21.3 Accord Pharmaceuticals Oral Finasteride Tablet Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Accord Pharmaceuticals Oral Finasteride Tablet Product Portfolio
  126. 8.21.5 Accord Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Oral Finasteride Tablet Value Chain Analysis
  2. 9.1.1 Oral Finasteride Tablet Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Oral Finasteride Tablet Sales Mode & Process
  6. 9.2 Oral Finasteride Tablet Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Oral Finasteride Tablet Distributors
  9. 9.2.3 Oral Finasteride Tablet Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst